Pharmaceutical temperature controlled supply chain community unveil challenges, priorities and the impact of the ambient supply chain in exclusive infographic

TP3 Global recently launched a community wide survey across the life sciences temperature controlled supplyNTI_TP3_GLOBAL_22 chain industry. The aim of this research was to find out more about how the life sciences and logistics industries are coping with increased regulatory and cost pressures whilst maintaining risk and excursion levels, particularly in light of the game changing EU GDP guidelines.

A series of questions covering priorities, risk factors, transportation methods, validation and thermal covers as a solution were posed to the temperature controlled supply chain community. This cross section included pharmaceutical and biotechnology companies, freight forwarders and third party logistics providers, in order to better understand the state of the industry, impact of regulatory pressures and the impact of increasing globalisation of supply chains.


It has been revealed that the biggest risk factor facing the industry is the increased overall cost due to ambient supply chain temperature control measures required by the European Medicines Association and all European regulatory authorities.

Temperature sensitive supply chain: Risk Factors


About TP3 Global

Focusing on passive protection of temperature sensitive cargo during transit, TP3 Global Ltd. was founded in the UK and has manufacturing bases in the Americas, Europe and Asia. TP3 Global’s range of SilverSkinTM thermal pallet covers are qualified, GDP compliant and designed for protection of cold chain and controlled room temperature shipments. TP3 Global works with the world’s largest Pharmaceutical, Healthcare and Perishable companies who have qualified SilverSkinTM insulated thermal pallet covers, blankets and wraps to support their cold chain, logistics and supply chain management needs.

Download as PDF